Revolution Medicines target price raised to $272 from $255
RVMD•Morgan Stanley raised its target price for Revolution Medicines to $272 from $255.
Related News
AMEX halts trading in GNMX
GNMX•
Warrior Met Coal target price cut to $97 from $102
HCC•
Medline Inc.: UBS raises target price to $49 from $43
MDLN•
UBS raises Zimmer Biomet target price to $130 from $120
ZBH•
Merit Medical reports 92.7% six-month target lesion primary patency for WRAPSODY in AVF registry cohort
MMSI•